BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24057543)

  • 1. Totally implantable vascular access devices in 131 pediatric oncology patients.
    Sola JE; Stone MM; Colombani PM
    Pediatr Surg Int; 1996 Mar; 11(2-3):156-8. PubMed ID: 24057543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and Risk Factors for Totally Implantable Venous Access Device Infections in Pediatric Patients With Cancer: A Study of 25,954 Device-Days.
    Lee JK; Choi YB
    J Korean Med Sci; 2022 Sep; 37(35):e266. PubMed ID: 36065650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days.
    Biffi R; de Braud F; Orsi F; Pozzi S; Mauri S; Goldhirsch A; Nolè F; Andreoni B
    Ann Oncol; 1998 Jul; 9(7):767-73. PubMed ID: 9739444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morbidity of chemotherapy administration and satisfaction in breast cancer patients: a comparative study of totally implantable venous access device (TIVAD) versus peripheral venous access usage.
    Singh KR; Agarwal G; Nanda G; Chand G; Mishra A; Agarwal A; Verma AK; Mishra SK; Goyal P
    World J Surg; 2014 May; 38(5):1084-92. PubMed ID: 24305930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.
    Biffi R; Corrado F; de Braud F; de Lucia F; Scarpa D; Testori A; Orsi F; Bellomi M; Mauri S; Aapro M; Andreoni B
    Eur J Cancer; 1997 Jul; 33(8):1190-4. PubMed ID: 9301441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the time-to-removal of totally implantable venous access devices comparing valved-versus open-ended catheters in patients treated with chemotherapy.
    Amroun K; Brugel M; Rhaiem R; Teuma L; Vannieuwenhuyse G; Lipere A; Brenet E; Kianmanesh R; Bouché O
    J Vasc Access; 2024 Jan; ():11297298231223539. PubMed ID: 38205615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications related to totally implantable venous access devices in children and adults following lung transplantation.
    Cho JK; Acord M; Goldfarb SB; Reddy SN; Goldberg HJ; Courtwright AM
    Clin Transplant; 2019 Feb; 33(2):e13465. PubMed ID: 30561770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical review and analysis of complications of totally implantable venous access devices for chemotherapy.
    Kim JT; Oh TY; Chang WH; Jeong YK
    Med Oncol; 2012 Jun; 29(2):1361-4. PubMed ID: 21380779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infections associated with totally implantable venous access devices (TIVAD) in human immunodeficiency virus-infected patients.
    Dega H; Eliaszewicz M; Gisselbrecht M; Fleury J; Pialoux G; Janssen B; de Saint-Martin L; Gonzalez-Canali G; Dupont B
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Oct; 13(2):146-54. PubMed ID: 8862279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Internal jugular vein versus subclavian vein as the percutaneous insertion site for totally implantable venous access devices: a meta-analysis of comparative studies.
    Wu S; Huang J; Jiang Z; Huang Z; Ouyang H; Deng L; Lin W; Guo J; Zeng W
    BMC Cancer; 2016 Sep; 16(1):747. PubMed ID: 27658952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seat belt associated central line fracture--a previously unreported complication in cystic fibrosis.
    Ghayyda SN; Roland D; Cade A
    J Cyst Fibros; 2008 Sep; 7(5):448-9. PubMed ID: 18455967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of Percutaneous Puncture in Insertion of Totally Implantable Venous Access Devices in Pediatric Patients.
    Choi JS; Park KM; Jung S; Hong KC; Jeon YS; Cho SG; Choe YM
    Vasc Specialist Int; 2017 Sep; 33(3):108-111. PubMed ID: 28955700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors of the Totally Implantable Venous Access Device-Related Infection in Patients With Brain Tumors Undergoing Chemotherapy After Surgery.
    Li H; Shan J
    Surg Infect (Larchmt); 2024 Mar; 25(2):133-139. PubMed ID: 38265425
    [No Abstract]   [Full Text] [Related]  

  • 14. Retrospective evaluation of totally implantable venous access port devices: early and late complications.
    Gurkan S; Seber S; Gur O; Yetisyigit T; Okan Donbaloglu M; Ozkaramanli Gur D
    J BUON; 2015; 20(1):338-45. PubMed ID: 25778336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of antibiotics in preventing totally implantable venous access device (TIVAD) infections; is there a population that would benefit?
    Jo JE; Tang EY; Pua BB
    Clin Imaging; 2018; 51():213-216. PubMed ID: 29864730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection assessment of totally implanted long-term venous access devices.
    Brouns F; Schuermans A; Verhaegen J; De Wever I; Stas M
    J Vasc Access; 2006; 7(1):24-8. PubMed ID: 16596525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radio-opacity and incidental identified mechanical complications of totally implantable venous access devices placed in the chest.
    Surov A; Rusner C; Weigand K; John E; Spielmann RP; Behrmann C
    Acta Radiol; 2012 Nov; 53(9):1035-9. PubMed ID: 23028172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Totally Implantable Venous Access Device Care Practices and Experiences of Pediatric and Adult Oncology Nurses.
    Gündogdu F; Semerci R; Bay F
    J Infus Nurs; 2024 May-Jun 01; 47(3):182-189. PubMed ID: 38744243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chinese expert consensus on the nursing management of the totally implantable venous access device.
    Xu Y; Fei XY; Xue YH; Wang XM; Wang XY; Zheng YT; Chen K; He JJ; Ren XH; Pan L; Wang L; Qian D; Li WF; Liang Y; Fang Y; Huang XF; Li CH; Chen DP; Wang Y; Wen LH; Zhang YH; Zheng Y; Song H; Lin YC; Zhang Q; Yang RM; Wang ZM
    J Cancer Res Ther; 2022 Sep; 18(5):1231-1240. PubMed ID: 36204867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of chemotherapy type and timing among the other factors on patency of totally implantable vascular access devices in colorectal carcinoma.
    Aribas BK; Yildiz F; Uylar T; Tiken R; Aydin H; Akdulum I; Seber T; Caglar E; Savran B; Aribas O
    J Vasc Access; 2021 Nov; ():11297298211059263. PubMed ID: 34796758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.